EUVIMEDEUVIMED entdecken
Crossref

A NIR‐Light‐Activated and Lysosomal‐Targeted Pt(II) Metallacycle for Highly Potent Evoking of Immunogenic Cell Death that Potentiates Cancer Immunotherapy of Deep‐Seated Tumors

Chonglu Li, Le Tu, Yuling Xu, Meiqin Li, Jiaxing Du, Peter J Stang iD, Yan Sun, Yao Sun

Angewandte Chemie International Edition · 09.09.2024 · 63 (37)

DOI: 10.1002/anie.202406392 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 30.06.2024. Verfasst von Chonglu Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Green Pesticide, International Joint Research Center for Intelligent Biosensor Technology and Health, College of Chemistry, C…. Hauptthemen laut MEDLINE: Immunogenic Cell Death, Immunotherapy, Infrared Rays, Lysosomes. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province, Fundamental Research Funds for Central Universities of the Central South University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Though platinum (Pt)‐based complexes have been recently exploited as immunogenic cell death (ICD) inducers for activating immunotherapy, the effective activation of sufficient immune responses with minimal side effects in deep‐seated tumors remains a formidable challenge. Herein, we propose the first example of a near‐infrared (NIR) light‐activated and lysosomal targeted Pt(II) metallacycle ( 1 ) as a supramolecular ICD inducer. 1 synergistically potentiates immunomodulatory response in deep‐seated tumors via multiple‐regulated approaches, involving NIR light excitation, boosted reactive oxygen species (ROS) generation, good selectivity between normal and tumor cells, and enhanced tumor penetration/retention capabilities. Specifically, 1 has excellent depth‐activated ROS production (~7 mm), accompanied by strong anti‐diffusion and anti‐ROS quenching ability. In vitro experiments demonstrate that 1 exhibits significant cellular uptake and ROS generation in tumor cells as well as respective multicellular tumor spheroids. Based on these advantages, 1 induces a more efficient ICD in an ultralow dose (i.e., 5 μM) compared with the clinical ICD inducer‐oxaliplatin (300 μM). In vivo , vaccination experiments further demonstrate that 1 serves as a potent ICD inducer through eliciting CD8 + /CD4 + T cell response and Foxp3 + T cell depletion with negligible adverse effects. This study pioneers a promising avenue for safe and effective metal‐based ICD agents in immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunogenic Cell DeathImmunotherapyInfrared RaysLysosomesReactive Oxygen SpeciesHumansAnimalsMiceAntineoplastic AgentsNeoplasmsCell Line, TumorPlatinumDrug Screening Assays, AntitumorOrganoplatinum Compounds

Stichwörter der Autor:innen

Deep-seated immune responsesImmunogenic cancer cell deathNIR activatedPt(II) metallacycle

Substanzen

Reactive Oxygen SpeciesAntineoplastic AgentsPlatinumOrganoplatinum Compounds

Autor:innen und Institutionen

  • State Key Laboratory of Green Pesticide, International Joint Research Center for Intelligent Biosensor Technology and Health, College of Chemistry, Central China, Normal University, Wuhan, 430079, China.
  • Key Laboratory for Special Functional Materials of Ministry of Education, School of Nanoscience and Materials Engineering, Henan University, Zhengzhou, 450046, China.
  • Department of Chemistry, University of Utah, 315 South 1400 East, Room 2020, Salt Lake City, UT 84112, USA.

ORCID-Profile: Peter J Stang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hubei Province
  • Fundamental Research Funds for Central Universities of the Central South University
  • Research Funds of Guangxi Key Laboratory of Environmental Pollution Control Theory and Technology
  • Open Foundation of the State Key Laboratory of Green Pesticide
  • Guangxi Key Laboratory of Environmental Pollution Control Theory and Technology

Zitieren

APA

Li, C., Tu, L., Xu, Y., Li, M., Du, J., Stang, P. J., Sun, Y., & Sun, Y. (2024). A NIR‐Light‐Activated and Lysosomal‐Targeted Pt(II) Metallacycle for Highly Potent Evoking of Immunogenic Cell Death that Potentiates Cancer Immunotherapy of Deep‐Seated Tumors. Angewandte Chemie International Edition, 63(37). https://doi.org/10.1002/anie.202406392

Vancouver

Li C, Tu L, Xu Y, Li M, Du J, Stang PJ, et al. A NIR‐Light‐Activated and Lysosomal‐Targeted Pt(II) Metallacycle for Highly Potent Evoking of Immunogenic Cell Death that Potentiates Cancer Immunotherapy of Deep‐Seated Tumors. Angewandte Chemie International Edition. 2024;63(37). doi:10.1002/anie.202406392

BibTeX
@article{Li2024,
  author = {Li, Chonglu and Tu, Le and Xu, Yuling and Li, Meiqin and Du, Jiaxing and Stang, Peter J and Sun, Yan and Sun, Yao},
  title = {A NIR‐Light‐Activated and Lysosomal‐Targeted Pt(II) Metallacycle for Highly Potent Evoking of Immunogenic Cell Death that Potentiates Cancer Immunotherapy of Deep‐Seated Tumors},
  journal = {Angewandte Chemie International Edition},
  year = {2024},
  volume = {63},
  number = {37},
  doi = {10.1002/anie.202406392}
}
Kostenlos starten →